133 related articles for article (PubMed ID: 38462823)
61. Cost-Effectiveness Analysis of Etranacogene Dezaparvovec Versus Extended Half-Life Prophylaxis for Moderate-to-Severe Haemophilia B in Germany.
Meier N; Fuchs H; Galactionova K; Hermans C; Pletscher M; Schwenkglenks M
Pharmacoecon Open; 2024 May; 8(3):373-387. PubMed ID: 38520664
[TBL] [Abstract][Full Text] [Related]
62. Once-weekly prophylactic treatment vs. on-demand treatment with nonacog alfa in patients with moderately severe to severe haemophilia B.
Kavakli K; Smith L; Kuliczkowski K; Korth-Bradley J; You CW; Fuiman J; Zupančić-Šalek S; Abdul Karim F; Rendo P
Haemophilia; 2016 May; 22(3):381-8. PubMed ID: 26823276
[TBL] [Abstract][Full Text] [Related]
63. Pharmacokinetics, safety and efficacy of a recombinant factor IX product, trenonacog alfa in previously treated haemophilia B patients.
Collins PW; Quon DVK; Makris M; Chowdary P; Kempton CL; Apte SJ; Ramanan MV; Hay CRM; Drobic B; Hua Y; Babinchak TJ; Gomperts ED
Haemophilia; 2018 Jan; 24(1):104-112. PubMed ID: 28833808
[TBL] [Abstract][Full Text] [Related]
64. AAV mediated gene therapy for haemophilia B: From the early attempts to modern trials.
Muczynski V; Nathwani AC
Thromb Res; 2024 Apr; 236():242-249. PubMed ID: 38383218
[TBL] [Abstract][Full Text] [Related]
65. Health-related quality of life among transthyretin amyloid cardiomyopathy patients.
Eldhagen P; Lehtonen J; Gude E; Gustafsson F; Bagger-Bahnsen A; Vakevainen M; Pilgaard T; Wedell-Wedellsborg D; Poulsen SH;
ESC Heart Fail; 2023 Jun; 10(3):1871-1882. PubMed ID: 36946241
[TBL] [Abstract][Full Text] [Related]
66. Effect of an Individually Tailored and Home-Based Intervention in the Chronic Phase of Traumatic Brain Injury: A Randomized Clinical Trial.
Borgen IMH; Løvstad M; Hauger SL; Forslund MV; Kleffelgård I; Andelic N; Sveen U; Søberg HL; Sigurdardottir S; Winter L; Lindstad MØ; Brunborg C; Røe C
JAMA Netw Open; 2023 May; 6(5):e2310821. PubMed ID: 37145600
[TBL] [Abstract][Full Text] [Related]
67. Recombinant factor IX-Fc fusion protein in severe hemophilia B: Patient-reported outcomes and health-related quality of life.
O'Donovan M; Quinn E; Johnston K; Singleton E; Benson J; O'Mahony B; Noone D; Duggan C; Gilmore R; Ryan K; O'Donnell JS; O'Connell NM; Mahlangu J
Res Pract Thromb Haemost; 2021 Oct; 5(7):e12602. PubMed ID: 34667923
[TBL] [Abstract][Full Text] [Related]
68. Health-related quality of life and its associated factors among hemophilia patients: experience from Ethiopian Hemophilia Treatment Centre.
Iyar S; Gebremariam GT; Beyene DA; Gebremedhin A; Tadesse TA
J Pharm Health Care Sci; 2024 Jan; 10(1):3. PubMed ID: 38167221
[TBL] [Abstract][Full Text] [Related]
69. The effects of joint disease, inhibitors and other complications on health-related quality of life among males with severe haemophilia A in the United States.
Soucie JM; Grosse SD; Siddiqi AE; Byams V; Thierry J; Zack MM; Shapiro A; Duncan N;
Haemophilia; 2017 Jul; 23(4):e287-e293. PubMed ID: 28574229
[TBL] [Abstract][Full Text] [Related]
70. Impact of hemophilia B on quality of life in affected men, women, and caregivers-Assessment of patient-reported outcomes in the B-HERO-S study.
Buckner TW; Witkop M; Guelcher C; Sidonio R; Kessler CM; Clark DB; Owens W; Frick N; Iyer NN; Cooper DL
Eur J Haematol; 2018 Jun; 100(6):592-602. PubMed ID: 29505680
[TBL] [Abstract][Full Text] [Related]
71. Health-related quality of life in people with advanced dementia: a comparison of EQ-5D-5L and QUALID instruments.
Sopina E; Chenoweth L; Luckett T; Agar M; Luscombe GM; Davidson PM; Pond CD; Phillips J; Goodall S
Qual Life Res; 2019 Jan; 28(1):121-129. PubMed ID: 30187395
[TBL] [Abstract][Full Text] [Related]
72. Progress towards gene therapy for haemophilia B.
Patel N; Reiss U; Davidoff AM; Nathwani AC
Int J Hematol; 2014 Apr; 99(4):372-6. PubMed ID: 24500177
[TBL] [Abstract][Full Text] [Related]
73. Health-related quality of life in HIV/AIDS patients on antiretroviral therapy at a tertiary care facility in Zimbabwe.
Mafirakureva N; Dzingirai B; Postma MJ; van Hulst M; Khoza S
AIDS Care; 2016 Jul; 28(7):904-12. PubMed ID: 27098289
[TBL] [Abstract][Full Text] [Related]
74. Decline in health-related quality of life and foot and ankle patient reported outcomes measures in patients with haemophilia and ankle haemarthropathy.
Wilkins RA; Siddle HJ; Chapman GJ; Horn E; Walwyn R; Redmond AC
J Foot Ankle Res; 2023 Mar; 16(1):12. PubMed ID: 36899385
[TBL] [Abstract][Full Text] [Related]
75. Determining the health-related quality of life in individuals with haemophilia in developing economies: results from the Brazilian population.
Salomon T; Chaves DG; Brener S; Martins PR; Mambrini JV; Peixoto SV
Haemophilia; 2017 Jan; 23(1):42-49. PubMed ID: 27928900
[TBL] [Abstract][Full Text] [Related]
76. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
77. Gene therapy for hemophilia.
Nathwani AC
Hematology Am Soc Hematol Educ Program; 2022 Dec; 2022(1):569-578. PubMed ID: 36485127
[TBL] [Abstract][Full Text] [Related]
78. Health-related quality of life in mild-to-moderate COVID-19 in the UK: a cross-sectional study from pre- to post-infection.
Soare IA; Ansari W; Nguyen JL; Mendes D; Ahmed W; Atkinson J; Scott A; Atwell JE; Longworth L; Becker F
Health Qual Life Outcomes; 2024 Jan; 22(1):12. PubMed ID: 38287294
[TBL] [Abstract][Full Text] [Related]
79. The health gap and HRQoL inequalities in Greece before and during the economic crisis.
Yfantopoulos J; Chantzaras A; Yfantopoulos P
Front Public Health; 2023; 11():1138982. PubMed ID: 37342272
[TBL] [Abstract][Full Text] [Related]
80. Safety and activity of an engineered, liver-tropic adeno-associated virus vector expressing a hyperactive Padua factor IX administered with prophylactic glucocorticoids in patients with haemophilia B: a single-centre, single-arm, phase 1, pilot trial.
Xue F; Li H; Wu X; Liu W; Zhang F; Tang D; Chen Y; Wang W; Chi Y; Zheng J; Du Z; Jiang W; Zhong C; Wei J; Zhu P; Fu R; Liu X; Chen L; Pei X; Sun J; Cheng T; Yang R; Xiao X; Zhang L
Lancet Haematol; 2022 Jul; 9(7):e504-e513. PubMed ID: 35598604
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
